Radient Technologies Inc
XTSX:RTI

Watchlist Manager
Radient Technologies Inc Logo
Radient Technologies Inc
XTSX:RTI
Watchlist
Price: 0.005 CAD Market Closed
Market Cap: 2.7m CAD

Relative Value

RTI doesn't have a meaningful market cap.

There is not enough data to reliably calculate the relative value of RTI.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RTI Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0.9
Median 5Y
0.9
Industry
2.6
vs History
vs Industry
Median 3Y
-0.2
Median 5Y
-0.2
Industry
21.6
vs History
vs Industry
Median 3Y
10.8
Median 5Y
10.8
Industry
16.5
vs History
vs Industry
Median 3Y
-2.2
Median 5Y
-2.2
Industry
22.5
vs History
vs Industry
Median 3Y
-0.2
Median 5Y
-0.2
Industry
2.3
vs History
vs Industry
Median 3Y
1.4
Median 5Y
1.4
Industry
2.9
vs History
vs Industry
Median 3Y
-36.8
Median 5Y
-36.8
Industry
5.5
vs History
vs Industry
Median 3Y
-0.9
Median 5Y
-0.9
Industry
13
vs History
vs Industry
Median 3Y
-0.7
Median 5Y
-0.7
Industry
16.6
vs History
vs Industry
Median 3Y
18.1
Median 5Y
18.1
Industry
15.8
vs History
vs Industry
Median 3Y
-4.6
Median 5Y
-4.6
Industry
19.1
vs History
vs Industry
Median 3Y
1
Median 5Y
1
Industry
1.9

Multiples Across Competitors

RTI Competitors Multiples
Radient Technologies Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Radient Technologies Inc
XTSX:RTI
2.7m CAD 0.9 -0.2 -0.9 -0.7
US
Eli Lilly and Co
NYSE:LLY
999.6B USD 16.8 54.3 36.4 39.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
501.2B USD 5.4 20 16.3 21.2
CH
Roche Holding AG
SIX:ROG
254.4B CHF 4.1 27 11.5 13.5
UK
AstraZeneca PLC
LSE:AZN
210.1B GBP 4.8 29.9 108.3 158.5
CH
Novartis AG
SIX:NOVN
206.7B CHF 4.6 18.1 11.5 14.8
US
Merck & Co Inc
NYSE:MRK
250.5B USD 3.9 13.2 9.4 11.1
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.3 13 9.1 10.6
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
142.4B USD 2.3 14.5 7.4 10.1
P/E Multiple
Earnings Growth PEG
CA
Radient Technologies Inc
XTSX:RTI
Average P/E: 23.7
Negative Multiple: -0.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.3
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20
29%
0.7
CH
Roche Holding AG
SIX:ROG
27
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
29.9
38%
0.8
CH
Novartis AG
SIX:NOVN
18.1
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.2
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13
4%
3.3
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.5
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Radient Technologies Inc
XTSX:RTI
Average EV/EBITDA: 438.7
Negative Multiple: -0.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36.4
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.3
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.5
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.3
10%
10.8
CH
Novartis AG
SIX:NOVN
11.5
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.4
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.1
2%
4.6
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
1%
7.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
Radient Technologies Inc
XTSX:RTI
Average EV/EBIT: 1 881.2
Negative Multiple: -0.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.1
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.2
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.5
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158.5
23%
6.9
CH
Novartis AG
SIX:NOVN
14.8
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11.1
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
10.6
1%
10.6
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.1
8%
1.3